327 related articles for article (PubMed ID: 18819423)
21. Effect of recombinant interleukin-5, interleukin-3, and eotaxin on apoptosis in eosinophilic granulocytes.
Ryazantseva NV; Novitskii VV; Litvinova LS; Tkachenko SB; Kolobovnikova YV; Zhukova OB; Grigor'eva ES; Suvorova EV; Knutareva EN; Radzivil TT; Chasovskikh NY
Bull Exp Biol Med; 2007 Apr; 143(4):395-8. PubMed ID: 18214283
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-5 induces CD34(+) eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma.
Stirling RG; van Rensen EL; Barnes PJ; Chung KF
Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1403-9. PubMed ID: 11704586
[TBL] [Abstract][Full Text] [Related]
23. Effect and mechanism of lipopolysaccharide on allergen-induced interleukin-5 and eotaxins production by whole blood cultures of atopic asthmatics.
Min JW; Park SM; Rhim TY; Park SW; Jang AS; Uh ST; Park CS; Chung IY
Clin Exp Immunol; 2007 Mar; 147(3):440-8. PubMed ID: 17302892
[TBL] [Abstract][Full Text] [Related]
24. Interactions between eotaxin and interleukin-5 in the chemotaxis of primed and non-primed human eosinophils.
Costa GG; Silva RM; Franco-Penteado CF; Antunes E; Ferreira HH
Eur J Pharmacol; 2007 Jul; 566(1-3):200-5. PubMed ID: 17368616
[TBL] [Abstract][Full Text] [Related]
25. [Increase of lysosomal cationic proteins of polymorphonuclear leukocytes as a response to opisthorchis invasion].
Iakovleva VV; Stepanova TF; Androsova EV; Postnikova TF; Shonin AL
Med Parazitol (Mosk); 2003; (2):7-10. PubMed ID: 12886583
[TBL] [Abstract][Full Text] [Related]
26. IL-5 and eosinophilia.
Takatsu K; Nakajima H
Curr Opin Immunol; 2008 Jun; 20(3):288-94. PubMed ID: 18511250
[TBL] [Abstract][Full Text] [Related]
27. Extraordinarily high eosinophilia and elevated serum interleukin-5 level observed in a patient infected with Paragonimus westermani.
Kan H; Ogata T; Taniyama A; Migita M; Matsuda I; Nawa Y
Pediatrics; 1995 Aug; 96(2 Pt 1):351-4. PubMed ID: 7630699
[TBL] [Abstract][Full Text] [Related]
28. Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease.
Kuo HC; Wang CL; Liang CD; Yu HR; Huang CF; Wang L; Hwang KP; Yang KD
Pediatr Allergy Immunol; 2009 May; 20(3):266-72. PubMed ID: 19438983
[TBL] [Abstract][Full Text] [Related]
29. Long-term exacerbation by interleukin 13 of IgE-mediated eosinophilia in rats.
Rossi MI; de Oliveira Barreto E; Pires AL; Rossi MI; Dias VA; Cordeiro RS; Martins MA; Lima MC
Int Immunopharmacol; 2005 Aug; 5(9):1353-64. PubMed ID: 15953562
[TBL] [Abstract][Full Text] [Related]
30. Eosinophilic pustular folliculitis effectively treated with recombinant interferon-gamma: suppression of mRNA expression of interleukin 5 in peripheral blood mononuclear cells.
Fushimi M; Tokura Y; Sachi Y; Hashizume H; Sudo H; Wakita H; Furukawa F; Takigawa M
Br J Dermatol; 1996 Apr; 134(4):766-72. PubMed ID: 8733389
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-5 and the posttreatment eosinophilia in patients with onchocerciasis.
Limaye AP; Abrams JS; Silver JE; Awadzi K; Francis HF; Ottesen EA; Nutman TB
J Clin Invest; 1991 Oct; 88(4):1418-21. PubMed ID: 1918387
[TBL] [Abstract][Full Text] [Related]
32. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis.
Konikoff MR; Blanchard C; Kirby C; Buckmeier BK; Cohen MB; Heubi JE; Putnam PE; Rothenberg ME
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1328-36. PubMed ID: 17059896
[TBL] [Abstract][Full Text] [Related]
33. Hepatocyte growth factor attenuates eotaxin and PGD2-induced chemotaxis of human eosinophils.
Ito W; Chiba T; Kanehiro A; Kato H; Yamaguchi K; Ueki S; Kayaba H; Chihara J
Allergy; 2007 Apr; 62(4):415-22. PubMed ID: 17362253
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of the interleukin 5 receptor alpha isoforms in blood and tissue eosinophils of nasal polyp patients.
Gevaert P; Hellman C; Lundblad L; Lundahl J; Holtappels G; van Cauwenberge P; Tavernier J; Bachert C
Allergy; 2009 May; 64(5):725-32. PubMed ID: 19170670
[TBL] [Abstract][Full Text] [Related]
35. [Severe eosinophilia in the acute phase of opisthorchis].
Polkovnikova VP; Svarovskaia TP
Sov Med; 1972 May; 35(5):134-5. PubMed ID: 5042676
[No Abstract] [Full Text] [Related]
36. Eosinophil activation status, cytokines and liver fibrosis in Schistosoma mansoni infected patients.
Silveira-Lemos D; Teixeira-Carvalho A; Martins-Filho OA; Alves Oliveira LF; Costa-Silva MF; Matoso LF; de Souza LJ; Gazzinelli A; Corrêa-Oliveira R
Acta Trop; 2008; 108(2-3):150-9. PubMed ID: 18550021
[TBL] [Abstract][Full Text] [Related]
37. CD8(+) T cells producing IL-3 and IL-5 in non-IgE-mediated eosinophilic diseases.
Stoeckle C; Simon HU
Allergy; 2013 Dec; 68(12):1622-5. PubMed ID: 24410785
[TBL] [Abstract][Full Text] [Related]
38. Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels.
Stein ML; Villanueva JM; Buckmeier BK; Yamada Y; Filipovich AH; Assa'ad AH; Rothenberg ME
J Allergy Clin Immunol; 2008 Jun; 121(6):1473-83, 1483.e1-4. PubMed ID: 18410960
[TBL] [Abstract][Full Text] [Related]
39. Effect of interleukin-3, interleukin 5 and hyaluronic acid on cultured eosinophils derived from human umbilical cord blood mononuclear cells.
Ohashi H; Takei M; Ide Y; Ishii H; Kita H; Gleich GJ; Ishikawa M; Fukamachi H
Int Arch Allergy Immunol; 1999 Jan; 118(1):44-50. PubMed ID: 9925962
[TBL] [Abstract][Full Text] [Related]
40. [Differences in the dynamics of the eosinophilia, blood immunoglobulin E and the level of circulating immune complexes in patients with chronic opisthorchiasis treated with different doses of praziquantel].
Legon'kov IuA; Ozeretskovskaia NN; Gervazieva VB; Ovsiannikova IG; Bronshteĭn AM
Med Parazitol (Mosk); 1992; (5-6):19-21. PubMed ID: 1299753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
